Literature DB >> 12970348

Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.

Karen L Soldano1, Arif Jivan, Christopher V Nicchitta, Daniel T Gewirth.   

Abstract

GRP94, the endoplasmic reticulum (ER) paralog of the chaperone Hsp90, plays an essential role in the structural maturation or secretion of a subset of proteins destined for transport to the cell surface, such as the Toll-like receptors 2 and 4, and IgG, respectively. GRP94 differs from cytoplasmic Hsp90 by exhibiting very weak ATP binding and hydrolysis activity. GRP94 also binds selectively to a series of substituted adenosine analogs. The high resolution crystal structures at 1.75-2.1 A of the N-terminal and adjacent charged domains of GRP94 in complex with N-ethylcarboxamidoadenosine, radicicol, and 2-chlorodideoxyadenosine reveals a structural mechanism for ligand discrimination among hsp90 family members. The structures also identify a putative subdomain that may act as a ligand-responsive switch. The residues of the charged region fold into a disordered loop whose termini are ordered and continue the twisted beta sheet that forms the structural core of the N-domain. This continuation of the beta sheet past the charged domain suggests a structural basis for the association of the N-terminal and middle domains of the full-length chaperone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970348     DOI: 10.1074/jbc.M308661200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum.

Authors:  Michal Marzec; Davide Eletto; Yair Argon
Journal:  Biochim Biophys Acta       Date:  2011-11-03

2.  Development of a Grp94 inhibitor.

Authors:  Adam S Duerfeldt; Laura B Peterson; Jason C Maynard; Chun Leung Ng; Davide Eletto; Olga Ostrovsky; Heather E Shinogle; David S Moore; Yair Argon; Christopher V Nicchitta; Brian S J Blagg
Journal:  J Am Chem Soc       Date:  2012-05-29       Impact factor: 15.419

3.  Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2.

Authors:  Pallav D Patel; Pengrong Yan; Paul M Seidler; Hardik J Patel; Weilin Sun; Chenghua Yang; Nanette S Que; Tony Taldone; Paola Finotti; Ralph A Stephani; Daniel T Gewirth; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2013-09-01       Impact factor: 15.040

4.  Identification of novel quaternary domain interactions in the Hsp90 chaperone, GRP94.

Authors:  Feixia Chu; Jason C Maynard; Gabriela Chiosis; Christopher V Nicchitta; Alma L Burlingame
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

5.  Integration-mediated prediction enrichment of quantitative model for Hsp90 inhibitors as anti-cancer agents: 3D-QSAR study.

Authors:  Kuldeep K Roy; Supriya Singh; Anil K Saxena
Journal:  Mol Divers       Date:  2010-08-26       Impact factor: 2.943

Review 6.  Functions of the Hsp90 chaperone system: lifting client proteins to new heights.

Authors:  Julia M Eckl; Klaus Richter
Journal:  Int J Biochem Mol Biol       Date:  2013-12-15

7.  Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Authors:  Hardik J Patel; Pallav D Patel; Stefan O Ochiana; Pengrong Yan; Weilin Sun; Maulik R Patel; Smit K Shah; Elisa Tramentozzi; James Brooks; Alexander Bolaender; Liza Shrestha; Ralph Stephani; Paola Finotti; Cynthia Leifer; Zihai Li; Daniel T Gewirth; Tony Taldone; Gabriela Chiosis
Journal:  J Med Chem       Date:  2015-04-22       Impact factor: 7.446

8.  The stress protein/chaperone Grp94 counteracts muscle disuse atrophy by stabilizing subsarcolemmal neuronal nitric oxide synthase.

Authors:  Maurizio Vitadello; Jennifer Gherardini; Luisa Gorza
Journal:  Antioxid Redox Signal       Date:  2013-11-26       Impact factor: 8.401

9.  5'-N-ethylcarboxamidoadenosine is not a paralog-specific Hsp90 inhibitor.

Authors:  Shanshan Liu; Timothy O Street
Journal:  Protein Sci       Date:  2016-10-04       Impact factor: 6.725

10.  Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

Authors:  Jin Wang; Anatoly V Grishin; Henri R Ford
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.